You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Trastuzumab biosimilar HLX02

Showing 1 - 25 of 1,170
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Malignant Solid Tumor Trial in Philadelphia (Biopsy, Biospecimen Collection, Echocardiography)

Active, not recruiting
  • Malignant Solid Neoplasm
  • Biopsy
  • +5 more
  • Philadelphia, Pennsylvania
    ECOG-ACRIN Cancer Research Group
Nov 15, 2023

Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma, Stage III Major Salivary Gland Cancer AJCC v8 Trial

Recruiting
  • Metastatic Salivary Gland Carcinoma
  • +4 more
  • New York, New York
    Memorial Sloane Kettering Cancer Center
Jan 11, 2023

Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Rectal Adenocarcinoma Trial in Scottsdale,

Not yet recruiting
  • Metastatic Colon Adenocarcinoma
  • +5 more
  • Trastuzumab
  • +2 more
  • Scottsdale, Arizona
  • +2 more
Jan 31, 2023

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Malignant Tumor in the Brain Trial in Duarte

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +2 more
  • Copper Cu 64-DOTA-Trastuzumab
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Nov 22, 2022

Anatomic Stage IV Breast Cancer AJCC v8, HER2-Positive Breast Carcinoma, Metastatic Breast Carcinoma Trial in United States

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +2 more
  • Los Angeles, California
  • +4 more
Jul 19, 2022

Metastatic Lung Non-Small Cell Carcinoma, Refractory Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer American Joint

Recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +4 more
  • Necitumumab
  • +4 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Jan 5, 2023

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial

Recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +19 more
  • pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 1, 2022

Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8

Recruiting
  • Anatomic Stage II Breast Cancer AJCC v8
  • +19 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
May 11, 2022

Breast Adenocarcinoma, Stage II Breast Cancer AJCC v6 and v7, Stage IIA Breast Cancer AJCC v6 and v7 Trial in United States

Recruiting
  • Breast Adenocarcinoma
  • +7 more
  • Multi-epitope HER2 Peptide Vaccine TPIV100
  • +5 more
  • Scottsdale, Arizona
  • +26 more
Aug 17, 2022

Advanced Malignant Solid Tumor, Estrogen Receptor Positive, HER2/Neu Positive Trial in United States (drug, other, biological)

Completed
  • Advanced Malignant Solid Neoplasm
  • +12 more
  • Houston, Texas
  • +4 more
Dec 16, 2020

Bladder Urothelial Carcinoma, Stage I Bladder Cancer AJCC v6 and v7, Stage II Bladder Cancer AJCC v6 and v7 Trial in Canada,

Completed
Has Results
  • Bladder Urothelial Carcinoma
  • +3 more
  • Mobile, Alabama
  • +183 more
Jun 28, 2022

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma Trial in

Not yet recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +14 more
  • Biopsy
  • +25 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jul 12, 2022

Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal

Completed
Has Results
  • Platinum-Resistant Fallopian Tube Carcinoma
  • +8 more
  • Bevacizumab
  • Irinotecan Sucrosofate
  • Chicago, Illinois
    Northwestern University
Dec 21, 2022

Male Breast Carcinoma, Stage IIA Breast Cancer AJCC v6 and v7, Stage IIB Breast Cancer AJCC v6 and v7 Trial in Puerto Rico,

Active, not recruiting
Has Results
  • Male Breast Carcinoma
  • +5 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Tucson, Arizona
  • +317 more
Mar 1, 2022

Endometrial Adenocarcinoma, ERBB2 Gene Amplification, Recurrent Uterine Corpus Carcinoma Trial in Philadelphia (Laboratory

Completed
  • Endometrial Adenocarcinoma
  • +4 more
  • Laboratory Biomarker Analysis
  • Trastuzumab
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
Jul 30, 2019

HER2/Neu Positive, Invasive Breast Carcinoma, Recurrent Breast Carcinoma Trial in Houston (drug, other, biological)

Completed
  • HER2/Neu Positive
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
May 17, 2019

Metastatic Breast Adenocarcinoma, Metastatic HER2-Positive Breast Carcinoma, Recurrent Breast Adenocarcinoma Trial in Canada,

Recruiting
  • Breast Adenocarcinoma
  • +8 more
  • Birmingham, Alabama
  • +667 more
Apr 6, 2022

Breast Ductal Carcinoma In Situ Trial in Worldwide (other, biological, radiation)

Active, not recruiting
Has Results
  • Breast Ductal Carcinoma In Situ
  • Laboratory Biomarker Analysis
  • +2 more
  • Anniston, Alabama
  • +1267 more
Jan 28, 2023

Breast Adenocarcinoma, HER2 Positive Breast Carcinoma, Stage IA Breast Cancer AJCC v7 Trial in Worldwide (drug, other,

Completed
  • Breast Adenocarcinoma
  • +6 more
  • Aromatase Inhibition Therapy
  • +6 more
  • Birmingham, Alabama
  • +156 more
Aug 13, 2020

HER2/Neu Positive, Progesterone Receptor Positive, Recurrent Breast Carcinoma Trial in Worldwide (drug, other, biological)

Active, not recruiting
Has Results
  • HER2/Neu Positive
  • +8 more
  • Anniston, Alabama
  • +1291 more
Jan 28, 2023

Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8

Recruiting
  • Anatomic Stage II Breast Cancer AJCC v8
  • +8 more
  • Birmingham, Alabama
  • +911 more
Aug 23, 2022

Breast Cancer, Breast Tumors, HER2-positive Breast Cancer Trial in Guanzhou (HLX11, EU-Perjeta®)

Recruiting
  • Breast Cancer
  • +2 more
  • Guanzhou, Guangdong, China
    Sun Yat-Sun Yat-sen Hospital affiliated to Sun Yat-sen Universit
Apr 28, 2022

HER2-Positive Breast Carcinoma, Hormone Receptor-Positive Breast Carcinoma, Stage IB Breast Cancer AJCC v7 Trial in Puerto Rico,

Active, not recruiting
  • HER2-Positive Breast Carcinoma
  • +7 more
  • Aromatase Inhibition Therapy
  • +10 more
  • Fairbanks, Alaska
  • +736 more
Oct 8, 2021

Her 2 Positive Breast Cancer, Breast Cancer Female, Breast Cancer Metastatic Trial in Boston (Sacituzumab Govitecan,

Not yet recruiting
  • Her 2 Positive Breast Cancer
  • +2 more
  • Sacituzumab Govitecan
  • +2 more
  • Boston, Massachusetts
  • +1 more
Oct 25, 2023

Metastatic Cancer, HER2 Gene Mutation Trial in Seoul (Neratinib Maleate)

Active, not recruiting
  • Metastatic Cancer
  • HER2 Gene Mutation
  • Neratinib Maleate
  • Seoul, Korea, Republic of
    Korea university Guro hospital
Oct 18, 2023